Shojaee Samira, Nana-Sinkam Patrick
Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, USA.
F1000Res. 2017 Dec 7;6:2110. doi: 10.12688/f1000research.11471.1. eCollection 2017.
Lung cancer is the number one cause of cancer-related death in both men and women. However, over the last few years, we have witnessed improved outcomes that are largely attributable to early detection, increased efforts in tobacco control, improved surgical approaches, and the development of novel targeted therapies. Currently, there are several novel therapies in clinical practice, including those targeting actionable mutations and more recently immunotherapeutic agents. Immunotherapy represents the most significant step forward in eradicating this deadly disease. Given the ever-changing landscape of lung cancer management, here we present an overview of the most recent advances in the management of non-small cell lung cancer.
肺癌是男性和女性癌症相关死亡的首要原因。然而，在过去几年中，我们见证了治疗效果的改善，这在很大程度上归因于早期检测、加大烟草控制力度、改进手术方法以及新型靶向治疗的发展。目前，临床实践中有几种新型疗法，包括针对可操作突变的疗法以及最近的免疫治疗药物。免疫疗法是根除这种致命疾病方面取得的最重大进展。鉴于肺癌治疗格局不断变化，在此我们概述非小细胞肺癌治疗的最新进展。
